Oct 09, 2019
44:29
For every 29 shares held, investors received 44. The price per share adjusted from $61.60 to $40.60.
The split itself did not change the total investment value.
Ryvu Therapeutics SA (GPW:RVU) operates in the Pharmaceuticals: major industry.
Ryvu Therapeutics SA company overviewRyvu Therapeutics SA's most recent stock split was on October 9, 2019. It was a 44-for-29 forward split, so shareholders received 44 shares for every 29 they held.
Ryvu Therapeutics SA has split its stock once. This history records one forward split, on October 9, 2019.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Ryvu Therapeutics SA's 44-for-29 split on October 9, 2019, every 29 shares became 44 shares.
Ryvu Therapeutics SA has not announced a new split in our records. Its most recent split was on October 9, 2019, 7 years ago. Companies announce splits in advance, and any new GPW:RVU split will appear on this page.
Already premium?